1) Waldvogel F.A.:Staphylococcus aureus. Principles and Practice and of Infectious Diseases (Mandell G. L. et al) Churchill Livingstone:1489-1510, 1990.
5) 菅野治重:細菌調査におけるMRSAの判定基準. 最新医学44:2510-2514, 1989.
7) Rahal J J.:Treatment of Methicillin Resistant Staphylococcal Infections. Antimicrobial Agents Annual 1:489-514, 1986.
8) 後藤 元ら:本邦における多剤耐性黄色ブドウ球菌の現況. Chemotherapy 37:1334-1341, 1989.
9) 小林寛伊:MRSA院内感染対策. 第93回日本医学会シンポジウム記録集. (日本医学会) 57-63, 1992.
10) 伊藤昌男:日米欧における抗菌薬の使用と開発状況. 最新医学44:2458-2465, 1989.
13) Valls V. et al.:Eflicacy of a Maintained Surveillance Program for Control of Multiple Antibiotic Resistant Staphylococcus aureus. Abstracts No 29 0f the 31st Intersci. Conf. Antimicrob. Agents Chemother. 1991.
15) Cookson B. et al.:Staff Carriage of Epidemic Methicillin Resistant Staphylococcus aureus. J. Clin. Microbiol. 27:1471-1476, 1989.
20) Craven D. E. et al.:Vancomycin Treatment of Bacteremia Caused by Oxacillin Resistant Staphylococcus aureus:Comparison with βLactam Antibiotic Treatment of Bacteremia caused by Oxacillin Sensitive Staphylococcus aureus. J. Inf. Dis. 147:137-143, 1983.
21) 島川 馨, 砂川慶介ら:塩酸バンコマイシンの臨床成績. 第38日本化学療法学会東日本支部総会, 1991.
22) Kucers A. & Bennett N. Mck.:Vallcomycin, The Use of Antibiotics, Lippincott.:1045-1072, 1987.
24) 南方 保ら:血液透析患者におけるVancomycin の血中動態と各種透析膜によるVancomycin の除去の検討:第 38 回日本化学療法学会東日本支部総会, 1991.
28) 後藤美江子, 古川恵一ら:臨床分離株, S.aureusに対するST合剤の薬剤感受性. 第38回日本化学療法学会東日本支部総会, 1991.
29) Markowitz N. et al.:Comparative efficacy and toxicity of Trimethoprim-Sulfamethoxazole versus Vancomycin in the therapy of serious Staphylococcus aureus infection. Infersci. Conf. Antimicrob. Agents Chemother. Abstracts No 903, 1985.
31) 古川恵一ら:ST合剤が有効であったMRSA感染症の11症例, 第40回日本化学療法学総会, 1992.
33) 古川恵一:米国臨床研修体験;理路整然とした感染症のチーム診療. 週刊医学界新聞1838号:3-4, 1989.
34) Bennett J. V.:Hospital Infection, Little, Brown, 1986.
39) Proctor M. E. et al.:Recommendations for control of Methicillin Resistant Staphylococcus aureus in acute and extended care facilities and for the transfer between facilities of patients colonized with MRSA. State of Wisconsin, Department of Health and Social Services, 1991.
40) Haley C. E. et al.:Bactericidal Activity of Antiseptics Against Methicillin Resistant Staphylococcus aureus. J. Clin. Microbiol. 21:991-992, 1985.
41) Mupirocin-a new topical antibiotic. Med. Lett. Drugs Ther. May 20;30 (766):55 56, 1988.
47) Maki D. G.:Strategies for Prevention of MRSA Infections. Update in Infectious Deseases, University of Wisconsinl. 1991. (Personal communications with Dr. Maki)